Spero Therapeutics, Inc. (SPRO)
2.93
+0.07
(+2.45%)
USD |
NASDAQ |
May 27, 16:00
2.93
0.00 (0.00%)
After-Hours: 19:41
Spero Therapeutics Free Cash Flow : 7.242M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| SELLAS Life Sciences Group, Inc. | -28.16M |
| Lantern Pharma, Inc. | -15.07M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Amgen, Inc. | 8.597B |